"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Current Issue

How the health reform is looking out for the industry in the long-term.

E-magazine
  • Previous Issues

Blog

Spencer Green
Chairman, GDS International

Sales and the 'Talent Magnet'

A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?
26 May 2011
Comments (Total 1 Comments)
Patrick Montgomery
Posted: 06 July 2010 @ 00:40

There are numerous benefits in choosing Neurogenesys Clinical Research when you conduct your next assessment. Some of these include..

The interview quality and reliability is directly related to the clinicians prior experience, training and educational background.
Neurogenesys Clinical Research only utilizes highly trained, credentialed clinicians to perform clinical trail assessments.
By employing "blinded" raters, Neurogenesys Clinical Research ensures that the data collected is reliable and accurate free from rater bias.
By eliminating rater bias, Neurogenesys Clinical Research eliminates over-inclusion of less severely symptomatic subjects, thereby, reducing future high screen failure rates. This also increases the number of potential subjects who are eligible for participation in the study.
Centralized raters refer to a small group of highly trained raters who are independent from the study sites and have no interest in study subject enrollment numbers.
Raters can be contracted based primarily on their clinical assessment experience as opposed to site operations or study coordinator/medical assistant experience.

Neurogenesys provides highly trained clinicians to perform centralized ratings to clinical research sites throughout the world. This is accomplished by providing expertly trained clinicians who will perform the screening/subject selection, and assessments throughout the trial by video conferencing. By utilizing clinicians who are totally autonomous from the site, it eliminates rater bias and subjective selection of subjects. The direct end point for sponsors is that protocol inclusion criteria are followed and qualified subjects are enrolled in the study. A direct result is that objective assessments are followed throughout the trial. Thus providing accurate data, a decrease in screen failures, and objective accurate assessments are completed throughout the course of the clinical trial. This results in helping efficacy of...

Disclaimer: All comments posted in a personal capacity